Evidence map›Paper›PMID 29280989›Full record

ArticleMolecules (Basel, Switzerland)2017

Design, Synthesis, and Biological Evaluation of Novel 1,3,4-Thiadiazole Derivatives as Potential Antitumor Agents against Chronic Myelogenous Leukemia: Striking Effect of Nitrothiazole Moiety.

Mehlika Dilek Altıntop, Halil Ibrahim Ciftci, Mohamed O Radwan, Belgin Sever, Zafer Asım Kaplancıklı, Taha F S Ali, Ryoko Koga, Mikako Fujita, Masami Otsuka, Ahmet Özdemir

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 70 citations in OpenAlex.

  1. Targeting G6PD with Benzimidazole and Thiazole Derivatives SuppressesInternational journal of molecular sciences · 2025
    Article
  2. Article
  3. Article
  4. Techniques and Strategies in Drug Design and Discovery.International journal of molecular sciences · 2024
    Article
  5. Review
  6. Synthesis of 1,3,4-Thiadiazole Derivatives and Their Anticancer Evaluation.International journal of molecular sciences · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. A New Series of Indeno[1,2-Molecules (Basel, Switzerland) · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Thiadiazole derivatives as anticancer agents.Pharmacological reports : PR · 2020
    Review
  17. Review
  18. Article
  19. Effects of Glycyrrhetic Acid on Human Chronic Myelogenous Leukemia Cells.Turkish journal of pharmaceutical sciences · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 4 countries.

Mehlika Dilek AltıntopDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskişehir 26470, Turkey. mdaltintop@anadolu.edu.tr.
Halil Ibrahim CiftciDepartment of Bioorganic Medicinal Chemistry, School of Pharmacy, Kumamoto University, Kumamoto 862-0973, Japan. hiciftci@kumamoto-u.ac.jp.
Mohamed O RadwanDepartment of Bioorganic Medicinal Chemistry, School of Pharmacy, Kumamoto University, Kumamoto 862-0973, Japan. mohamedosman251@gmail.com.
Belgin SeverDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskişehir 26470, Turkey. belginsever@anadolu.edu.tr.
Zafer Asım KaplancıklıDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskişehir 26470, Turkey. zakaplan@anadolu.edu.tr.
Taha F S AliDepartment of Bioorganic Medicinal Chemistry, School of Pharmacy, Kumamoto University, Kumamoto 862-0973, Japan. tahafarouk1@yahoo.com.
Ryoko KogaDepartment of Bioorganic Medicinal Chemistry, School of Pharmacy, Kumamoto University, Kumamoto 862-0973, Japan. kk1205@kumamoto-u.ac.jp.
Mikako FujitaResearch Institute for Drug Discovery, School of Pharmacy, Kumamoto University, Kumamoto 862-0973, Japan. mfujita@kumamoto-u.ac.jp.
Masami OtsukaDepartment of Bioorganic Medicinal Chemistry, School of Pharmacy, Kumamoto University, Kumamoto 862-0973, Japan. motsuka@gpo.kumamoto-u.ac.jp.
Ahmet ÖzdemirDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskişehir 26470, Turkey. ahmeto@anadolu.edu.tr.
Anadolu University · TRKumamoto University · JPMinia University · EGSLAC National Accelerator Laboratory · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In an attempt to develop potent antitumor agents, new 1,3,4-thiadiazole derivatives were synthesized and evaluated for their cytotoxic effects on multiple human cancer cell lines, including the K562 chronic myelogenous leukemia cell line that expresses the Bcr-Abl tyrosine kinase.

Indexed as

Antineoplastic AgentsBinding SitesCell Line, TumorCell SurvivalDrug Screening Assays, AntitumorFusion Proteins, bcr-ablHumansHydrophobic and Hydrophilic InteractionsInhibitory Concentration 50Leukemia, Myelogenous, Chronic, BCR-ABL PositiveMagnetic Resonance SpectroscopyModels, MolecularProtein BindingSpectrometry, Mass, Electrospray IonizationThiadiazoles1,3,4-thiadiazoleAntineoplastic AgentsFusion Proteins, bcr-ablThiadiazolesBcr-Ablbenzothiazolekinase inhibitorleukemiathiadiazolethiazole

Identifiers

PMID29280989
PMCPMC6017545
OpenAlexW2776669766

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.